The Decrease in Breast-Cancer Incidence in 2003 in the United States
Top Cited Papers
Open Access
- 19 April 2007
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (16), 1670-1674
- https://doi.org/10.1056/nejmsr070105
Abstract
An initial analysis of data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registries shows that the age-adjusted incidence rate of breast cancer in women in the United States fell sharply (by 6.7%) in 2003, as compared with the rate in 2002. Data from 2004 showed a leveling off relative to the 2003 rate, with little additional decrease. Regression analysis showed that the decrease began in mid-2002 and had begun to level off by mid-2003. A comparison of incidence rates in 2001 with those in 2004 (omitting the years in which the incidence was changing) showed that the decrease in annual age-adjusted incidence was 8.6% (95% confidence interval [CI], 6.8 to 10.4). The decrease was evident only in women who were 50 years of age or older and was more evident in cancers that were estrogen-receptor–positive than in those that were estrogen-receptor–negative. The decrease in breast-cancer incidence seems to be temporally related to the first report of the Women's Health Initiative and the ensuing drop in the use of hormone-replacement therapy among postmenopausal women in the United States. The contributions of other causes to the change in incidence seem less likely to have played a major role but have not been excluded.Keywords
This publication has 13 references indexed in Scilit:
- Recent Declines in Hormone Therapy Utilization and Breast Cancer Incidence: Clinical and Population-Based EvidenceJournal of Clinical Oncology, 2006
- Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populationsCancer, 2006
- Hormone Therapy Prescribing Patterns in the United StatesObstetrics & Gynecology, 2004
- National Use of Postmenopausal Hormone TherapyJAMA, 2004
- Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinomaCancer, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Breast Tumor Characteristics as Predictors of Mammographic Detection: Comparison of Interval- and Screen-Detected CancersJNCI Journal of the National Cancer Institute, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Breast cancer response to hormone replacement therapy withdrawalThe Lancet, 1995